Answers are grounded in this paper and cite their sources.
Shows RXR agonist upregulates GM-CSF production in intraepithelial T cells, indicating immune regulation in the gut.
Context-dependent cytokine granulocyte–macrophage colony-stimulating factor (GM-CSF) plays a crucial role in maintaining intestinal immune homeostasis and exacerbating inflammation. Although multiple cell types produce GM-CSF in the gut, whether intraepithelial lymphocytes (IELs) contribute to GM-CSF production during the steady state remains unclear. In the small intestinal epithelial layer, we identified B220-expressing CD8αα + T cells that selectively produced GM-CSF but not interleukin-17A or interferon-γ. Transcriptional analysis combined with weighted parametric gene set analysis revealed the upregulation of retinoid X receptor (RXR)-related genes in this population. Consistently, the RXR agonist bexarotene increased GM-CSF-producing B220 + CD8αα + T cells without affecting other cytokines or CD8αβ + T cells. These findings identify B220 + CD8αα + IELs as a spatially distinct source of GM-CSF in the epithelial layer and indicate that the RXR pathway specifically promotes the GM-CSF-producing program, potentially contributing to maintaining immune homeostasis in the small intestine.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: